Sangho Roh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sangho Roh has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- Sangkyu Park
Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Korea
17 shared publications - Jeongmin Seo
Biomedical Research Institute, NeoRegen Biotech Co., Ltd., Seocho-gu 06663, Republic of Korea; Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul 08826, Republic of Korea
12 shared publications Na Ahn
Department of Companion Animal Health Care, Kyung-In Women’s University 4
7 shared publicationsDaehwan Kim
Cellular Reprogramming and Embryo Biotechnology Laboratory, Dental Research Institute, Seoul National University School of Dentistry, Seoul, Republic of Korea
6 shared publications- Hyewon Kim
Department of Dental Science, Dental Research Institute, School of Dentistry, Seoul National University , Seoul 03080
6 shared publications - Jaehoon Lee
R&D Headquarter Korea Ginseng Corporation Gwacheon‐si Korea
6 shared publications
Latest Publications
- Open Access
- 20 November 2026
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 17
Secretomes from the transient iPSC reprogramming phase promote skin wound healing and extend Caenorhabditis elegans lifespan
Somatic cell reprogramming involves extensive remodeling of cellular identity, but whether cells undergoing this transition generate a functionally distinct and therapeutically relevant secretome remains unclear. Here, we investigated whether conditioned medium collected during the reprogramming of human dermal fibroblasts (HDFs) into induced pluripotent stem cells (iPSCs), termed reprogramming-conditioned medium (Repro-CM), could promote skin wound healing and support fibroblast recovery after ultraviolet A (UVA)-induced damage. Compared with conditioned medium from parental HDFs (HDF-CM) or established iPSCs (iPSC-CM), Repro-CM significantly increased the viability and scratch-wound closure of UVA-irradiated HDFs while reducing apoptosis. In a mouse excisional skin wound model, Repro-CM reduced wound area and increased the number of vWF-positive vessels at the wound edge. Repro-CM administration also prolonged the lifespan of wild-type Caenorhabditis elegans , supporting bioactivity across cellular and organismal levels. RNA sequencing of Repro-CM-treated HDFs revealed coordinated remodeling of stress-response and proteostasis-related pathways, together with attenuation of cell-cycle-associated transcriptional programs. Extracellular microRNA profiling further identified a Repro-CM-biased signature involving members of the miR-302 and let-7 families, while secretome profiling identified tissue inhibitor of metalloproteinases 2 (TIMP2) as a prominent candidate mediator. Collectively, these findings demonstrate that cells undergoing reprogramming produce a transient bioactive secretome distinct from those of both parental fibroblasts and fully reprogrammed iPSCs. Repro-CM therefore represents a candidate “cell-free strategy” for supporting fibroblast recovery and skin wound healing and provides a basis for identifying reprogramming-associated paracrine factors that support cellular stress resistance and functional recovery.
- 20 November 2026
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 17
Open AccessSecretomes from the transient iPSC reprogramming phase promote skin wound healing and extend Caenorhabditis elegans lifespan
Somatic cell reprogramming involves extensive remodeling of cellular identity, but whether cells undergoing this transition generate a functionally distinct and therapeutically relevant secretome remains unclear. Here, we investigated whether conditioned medium collected during the reprogramming of human dermal fibroblasts (HDFs) into induced pluripotent stem cells (iPSCs), termed reprogramming-conditioned medium (Repro-CM), could promote skin wound healing and support fibroblast recovery after ultraviolet A (UVA)-induced damage. Compared with conditioned medium from parental HDFs (HDF-CM) or established iPSCs (iPSC-CM), Repro-CM significantly increased the viability and scratch-wound closure of UVA-irradiated HDFs while reducing apoptosis. In a mouse excisional skin wound model, Repro-CM reduced wound area and increased the number of vWF-positive vessels at the wound edge. Repro-CM administration also prolonged the lifespan of wild-type Caenorhabditis elegans , supporting bioactivity across cellular and organismal levels. RNA sequencing of Repro-CM-treated HDFs revealed coordinated remodeling of stress-response and proteostasis-related pathways, together with attenuation of cell-cycle-associated transcriptional programs. Extracellular microRNA profiling further identified a Repro-CM-biased signature involving members of the miR-302 and let-7 families, while secretome profiling identified tissue inhibitor of metalloproteinases 2 (TIMP2) as a prominent candidate mediator. Collectively, these findings demonstrate that cells undergoing reprogramming produce a transient bioactive secretome distinct from those of both parental fibroblasts and fully reprogrammed iPSCs. Repro-CM therefore represents a candidate “cell-free strategy” for supporting fibroblast recovery and skin wound healing and provides a basis for identifying reprogramming-associated paracrine factors that support cellular stress resistance and functional recovery.
- Open Access
- 1 July 2026
- Published by Bioscientifica in Reproduction and Fertility
- Vol. 7 (3)
Explainable AI consensus for grading human blastocysts and blastoids
Graphical The morphological evaluation of human blastocysts is a critical yet subjective step in clinical assisted reproductive technology (ART), often limited by inter-observer variability. To establish a standardized and objective grading system for both clinical blastocysts and stem cell-derived blastoids, we developed an explainable artificial intelligence-driven multi-model consensus framework. Our methodology utilized a large-scale dataset of 14,846 bright-field images (14,640 blastocysts and 206 blastoids), with the Gardner grading system (Grades 1–5) established as the ground truth by experienced embryologists. High-quality embryos were defined as those reaching expansion Grades 4 or 5 with robust inner cell mass (ICM) and trophectoderm scores. To prevent data leakage and ensure generalizability, the dataset was strictly partitioned into training and testing sets at the individual embryo/blastoid level rather than the image level. The framework integrates an ensemble of four fine-tuned convolutional neural networks (ResNet18, VGG16-BN, ResNet50, and EfficientNet-B0) for visual assessment, complemented by visual explainability via Grad-CAM and cognitive reasoning via the Gemini 2.5 Flash large language model (LLM). Quantitative evaluation revealed that the LLM meta-model achieved a weighted F1-score of 0.99, demonstrating functional equivalence to the statistical upper bound established by an XGBoost meta-model (F1-score: 1.00). Grad-CAM analysis confirmed that the models’ decisions were biologically grounded, with high-quality predictions consistently correlating with high focus scores on the ICM. Furthermore, t-SNE visualization provided objective evidence of morphological similarity between clinical blastocysts and H9-derived blastoids. This hybrid framework establishes a new benchmark for objective, interpretable embryo grading and validates blastoids as a robust model system. Lay summary: In fertility clinics, selecting the best embryo for in vitro fertilization relies on visual inspection by experts, which can be subjective and inconsistent. In this study, ‘clinical blastocysts’ refers to early human embryos generated during ART procedures and imaged at the blastocyst stage before clinical decision-making. Scientists also use ‘stem cell-derived blastoids’, which are blastocyst-like structures generated from human stem cells in the laboratory. They are not embryos, but research models that reproduce selected structural features of early blastocysts and can help researchers study early human development under controlled laboratory conditions. To improve the evaluation of both clinical blastocysts and stem cell-derived blastoids, we developed an artificial intelligence system that acts like a panel of experts. First, the computer visually inspects thousands of images. Then, an advanced language model reviews these visual clues to agree on a final grade and explains its reasoning in simple text. We found that this system was accurate and interpretable because it highlighted which parts of the image it used to make its decision. This technology may help standardize embryo morphology assessment in fertility treatment and support early-development research by evaluating whether stem cell-derived blastoids share selected visible features with clinical blastocysts.
- 1 July 2026
- Published by Bioscientifica in Reproduction and Fertility
- Vol. 7 (3)
Open AccessExplainable AI consensus for grading human blastocysts and blastoids
Graphical The morphological evaluation of human blastocysts is a critical yet subjective step in clinical assisted reproductive technology (ART), often limited by inter-observer variability. To establish a standardized and objective grading system for both clinical blastocysts and stem cell-derived blastoids, we developed an explainable artificial intelligence-driven multi-model consensus framework. Our methodology utilized a large-scale dataset of 14,846 bright-field images (14,640 blastocysts and 206 blastoids), with the Gardner grading system (Grades 1–5) established as the ground truth by experienced embryologists. High-quality embryos were defined as those reaching expansion Grades 4 or 5 with robust inner cell mass (ICM) and trophectoderm scores. To prevent data leakage and ensure generalizability, the dataset was strictly partitioned into training and testing sets at the individual embryo/blastoid level rather than the image level. The framework integrates an ensemble of four fine-tuned convolutional neural networks (ResNet18, VGG16-BN, ResNet50, and EfficientNet-B0) for visual assessment, complemented by visual explainability via Grad-CAM and cognitive reasoning via the Gemini 2.5 Flash large language model (LLM). Quantitative evaluation revealed that the LLM meta-model achieved a weighted F1-score of 0.99, demonstrating functional equivalence to the statistical upper bound established by an XGBoost meta-model (F1-score: 1.00). Grad-CAM analysis confirmed that the models’ decisions were biologically grounded, with high-quality predictions consistently correlating with high focus scores on the ICM. Furthermore, t-SNE visualization provided objective evidence of morphological similarity between clinical blastocysts and H9-derived blastoids. This hybrid framework establishes a new benchmark for objective, interpretable embryo grading and validates blastoids as a robust model system. Lay summary: In fertility clinics, selecting the best embryo for in vitro fertilization relies on visual inspection by experts, which can be subjective and inconsistent. In this study, ‘clinical blastocysts’ refers to early human embryos generated during ART procedures and imaged at the blastocyst stage before clinical decision-making. Scientists also use ‘stem cell-derived blastoids’, which are blastocyst-like structures generated from human stem cells in the laboratory. They are not embryos, but research models that reproduce selected structural features of early blastocysts and can help researchers study early human development under controlled laboratory conditions. To improve the evaluation of both clinical blastocysts and stem cell-derived blastoids, we developed an artificial intelligence system that acts like a panel of experts. First, the computer visually inspects thousands of images. Then, an advanced language model reviews these visual clues to agree on a final grade and explains its reasoning in simple text. We found that this system was accurate and interpretable because it highlighted which parts of the image it used to make its decision. This technology may help standardize embryo morphology assessment in fertility treatment and support early-development research by evaluating whether stem cell-derived blastoids share selected visible features with clinical blastocysts.
- 10 June 2026
- Published by SAGE Publications in Laboratory Animals
Occupational stress, ethical conflicts, and job satisfaction in animal research environments in Korea
Professionals engaged in animal experimentation within laboratory animal facilities face a range of practical hardships, including emotional distress, professional stress, ethical conflicts, and work environment-related challenges. To address these issues, it is crucial to systematically identify the psychological and emotional burdens, as well as the specific stressors, experienced by individuals in this field. This study examines the ethical conflicts and compassion fatigue encountered by personnel working with laboratory animals in Korea. An online survey was conducted with 165 participants, including animal researchers (laboratory technicians, postdoctoral researchers, and graduate students), principal investigators, animal facility managers, and attending veterinarians. The results indicated that animal researchers experienced lower levels of stress and fewer ethical dilemmas than other occupational groups, including principal investigators, attending veterinarians, and animal facility managers. Female respondents reported a higher frequency of ethical dilemmas than male respondents, regardless of occupational role. Participants with less than six years of work experience reported fewer ethical dilemmas than those with longer tenure, suggesting that ethical sensitivity might increase with prolonged exposure to animal experimentation. Euthanasia and animal pain were identified as the primary sources of ethical stress. Multivariate logistic regression analysis revealed that experiences of ethical dilemmas, years of employment, and occupational role were significantly associated with stress levels. These findings underscore the need for organizational-level interventions to mitigate ethical stress and promote a healthier research environment. Strengthening emotional resilience and supporting the overall well-being of personnel working with laboratory animals are essential goals of such efforts.
- 10 June 2026
- Published by SAGE Publications in Laboratory Animals
Occupational stress, ethical conflicts, and job satisfaction in animal research environments in Korea
Professionals engaged in animal experimentation within laboratory animal facilities face a range of practical hardships, including emotional distress, professional stress, ethical conflicts, and work environment-related challenges. To address these issues, it is crucial to systematically identify the psychological and emotional burdens, as well as the specific stressors, experienced by individuals in this field. This study examines the ethical conflicts and compassion fatigue encountered by personnel working with laboratory animals in Korea. An online survey was conducted with 165 participants, including animal researchers (laboratory technicians, postdoctoral researchers, and graduate students), principal investigators, animal facility managers, and attending veterinarians. The results indicated that animal researchers experienced lower levels of stress and fewer ethical dilemmas than other occupational groups, including principal investigators, attending veterinarians, and animal facility managers. Female respondents reported a higher frequency of ethical dilemmas than male respondents, regardless of occupational role. Participants with less than six years of work experience reported fewer ethical dilemmas than those with longer tenure, suggesting that ethical sensitivity might increase with prolonged exposure to animal experimentation. Euthanasia and animal pain were identified as the primary sources of ethical stress. Multivariate logistic regression analysis revealed that experiences of ethical dilemmas, years of employment, and occupational role were significantly associated with stress levels. These findings underscore the need for organizational-level interventions to mitigate ethical stress and promote a healthier research environment. Strengthening emotional resilience and supporting the overall well-being of personnel working with laboratory animals are essential goals of such efforts.
- Open Access
- 30 December 2025
- Published by Wiley in Molecular Oncology
- Vol. 20 (6) , 1591-1611
Dammarenediol II enhances etoposide‐induced apoptosis by targeting O ‐ GlcNAc transferase and Akt/ GSK3β / mTOR signaling in liver cancer
Combining chemotherapy with chemosensitizing agents is a common strategy to enhance anticancer efficacy while mitigating treatment‐related side effects. This study investigated the potential of dammarenediol II (DM2), a ginsenoside precursor, to enhance the anticancer effects of etoposide by downregulating O ‐linked β‐N‐acetylglucosamine modification ( O ‐GlcNAcylation) and modulating the Akt signaling pathway in HepG2 human liver cancer cells. The effect of DM2 on O ‐GlcNAcylation regulation was analyzed using Pharmaco‐Net, an artificial intelligence–driven drug screening platform and further validated using O ‐GlcNAc transferase (OGT) activity assay. DM2 cotreatment enhanced etoposide's anticancer efficacy, which was quantitatively evaluated by viability, Annexin V binding, membrane integrity, and caspase‐3/7 activity assays in HepG2 cells. Results showed that DM2 reduced O ‐GlcNAc levels by directly interacting with OGT, as confirmed through Pharmaco‐Net. Cotreatment with 40 μ m DM2 and 20 μ m etoposide produced synergistic anticancer effects, lowering etoposide's IC 50 for cell viability by 2.29‐fold and its EC 50 for caspase‐3/7 activity by 3.64‐fold. Mechanistically, DM2 dose‐dependently suppressed Akt/GSK3β/mTOR signaling. Using the Akt activator SC79, additional experiments confirmed that Akt signaling acts downstream of O ‐GlcNAcylation regulated by etoposide and DM2. These effects were also observed in multiple human liver cancer cell lines, as well as in A549 lung and Caco‐2 colorectal cancer cells. This supports the broader anticancer and Akt‐inhibitory potential of DM2. This study is the first to demonstrate that DM2 enhances anticancer synergy by suppressing O ‐GlcNAcylation and Akt signaling, highlighting its potential as a novel chemotherapy adjuvant.
- 30 December 2025
- Published by Wiley in Molecular Oncology
- Vol. 20 (6) , 1591-1611
Open AccessDammarenediol II enhances etoposide‐induced apoptosis by targeting O ‐ GlcNAc transferase and Akt/ GSK3β / mTOR signaling in liver cancer
Combining chemotherapy with chemosensitizing agents is a common strategy to enhance anticancer efficacy while mitigating treatment‐related side effects. This study investigated the potential of dammarenediol II (DM2), a ginsenoside precursor, to enhance the anticancer effects of etoposide by downregulating O ‐linked β‐N‐acetylglucosamine modification ( O ‐GlcNAcylation) and modulating the Akt signaling pathway in HepG2 human liver cancer cells. The effect of DM2 on O ‐GlcNAcylation regulation was analyzed using Pharmaco‐Net, an artificial intelligence–driven drug screening platform and further validated using O ‐GlcNAc transferase (OGT) activity assay. DM2 cotreatment enhanced etoposide's anticancer efficacy, which was quantitatively evaluated by viability, Annexin V binding, membrane integrity, and caspase‐3/7 activity assays in HepG2 cells. Results showed that DM2 reduced O ‐GlcNAc levels by directly interacting with OGT, as confirmed through Pharmaco‐Net. Cotreatment with 40 μ m DM2 and 20 μ m etoposide produced synergistic anticancer effects, lowering etoposide's IC 50 for cell viability by 2.29‐fold and its EC 50 for caspase‐3/7 activity by 3.64‐fold. Mechanistically, DM2 dose‐dependently suppressed Akt/GSK3β/mTOR signaling. Using the Akt activator SC79, additional experiments confirmed that Akt signaling acts downstream of O ‐GlcNAcylation regulated by etoposide and DM2. These effects were also observed in multiple human liver cancer cell lines, as well as in A549 lung and Caco‐2 colorectal cancer cells. This supports the broader anticancer and Akt‐inhibitory potential of DM2. This study is the first to demonstrate that DM2 enhances anticancer synergy by suppressing O ‐GlcNAcylation and Akt signaling, highlighting its potential as a novel chemotherapy adjuvant.
- Open Access
- 15 October 2025
- Published by Springer Nature in Laboratory Animal Research
- Vol. 41 (1) , 1-8
The status of postapproval monitoring operation by the Institutional Animal Care and Use Committee in Korea
Background: Postapproval monitoring (PAM) is a critical component of Institutional Animal Care and Use Committee (IACUC) oversight, ensuring compliance with approved protocols and ethical animal research practices. While the PAM is not explicitly mandated under U.S. federal regulations, it has been widely recognized as an essential mechanism for verifying adherence to animal welfare standards. In contrast, Korea has formally integrated the PAM into its legal framework, making it a mandatory function of IACUCs. Results: This study examines the implementation and perception of the PAM in Korean institutions through a survey of relevant professionals. These findings indicate that while awareness of the PAM is high, challenges such as limited manpower and institutional support hinder its effective execution. Additionally, the pandemic highlighted the potential for online remote monitoring as a supplemental method, although concerns remain regarding its effectiveness in assessing real-time animal welfare conditions. The study suggests that a hybrid PAM model, that combines onsite and remote monitoring, could improve oversight efficiency while addressing resource constraints. Strengthening administrative support, increasing professional staffing, and enhancing researcher training are crucial steps for optimizing PAM operations in Korea. Conclusions: These insights contribute to the broader discourse on the evolution of animal research oversight and the need for adaptable monitoring strategies in diverse regulatory environments.
- 15 October 2025
- Published by Springer Nature in Laboratory Animal Research
- Vol. 41 (1) , 1-8
Open AccessThe status of postapproval monitoring operation by the Institutional Animal Care and Use Committee in Korea
Background: Postapproval monitoring (PAM) is a critical component of Institutional Animal Care and Use Committee (IACUC) oversight, ensuring compliance with approved protocols and ethical animal research practices. While the PAM is not explicitly mandated under U.S. federal regulations, it has been widely recognized as an essential mechanism for verifying adherence to animal welfare standards. In contrast, Korea has formally integrated the PAM into its legal framework, making it a mandatory function of IACUCs. Results: This study examines the implementation and perception of the PAM in Korean institutions through a survey of relevant professionals. These findings indicate that while awareness of the PAM is high, challenges such as limited manpower and institutional support hinder its effective execution. Additionally, the pandemic highlighted the potential for online remote monitoring as a supplemental method, although concerns remain regarding its effectiveness in assessing real-time animal welfare conditions. The study suggests that a hybrid PAM model, that combines onsite and remote monitoring, could improve oversight efficiency while addressing resource constraints. Strengthening administrative support, increasing professional staffing, and enhancing researcher training are crucial steps for optimizing PAM operations in Korea. Conclusions: These insights contribute to the broader discourse on the evolution of animal research oversight and the need for adaptable monitoring strategies in diverse regulatory environments.
- Open Access
- 16 February 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 184, 117913
Treatment with Lactobacillus paracasei L30 extract induces osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro
- 16 February 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 184, 117913
Open AccessTreatment with Lactobacillus paracasei L30 extract induces osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro
- Open Access
- 7 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0120
A Novel Cell-Penetrating Peptide–Vascular Endothelial Growth Factor Small Interfering Ribonucleic Acid Complex That Mediates the Inhibition of Angiogenesis by Human Umbilical Vein Endothelial Cells and in an Ex Vivo Mouse Aorta Ring Model
Angiogenesis is mediated by vascular endothelial growth factor (VEGF), a protein that plays a key role in wound healing, inflammatory diseases, cardiovascular processes, ocular diseases, and tumor growth. Indeed, modulation of angiogenesis represents a potential approach to treating cancer and, as such, therapeutic approaches targeting VEGF and its receptors have been widely investigated as part of the broader search for curative interventions. Equally, RNA interference is a powerful tool for treating diseases, but its application as a disease treatment has been limited in part because of a lack of efficient small interfering RNA (siRNA) delivery systems. The purpose of this study was to characterize an amphipathic cell-penetrating peptide, Ara27, and its potential as an effective delivery vehicle as a conjugate with VEGF siRNA (siVEGF). In our study, we demonstrate that exposure of human umbilical vein endothelial cells (HUVECs) with Ara27–siVEGF complexes did not lead to cytotoxicity and can lead to down-regulation of cellular levels of both VEGF mRNA and protein. Moreover, treatment with the Ara27–siVEGF complex attenuates the phosphorylation of VEGFR2, Akt, and ERK in HUVECs and inhibits their capacity for wound healing and tube formation, both of which characteristics reflective of angiogenesis. In addition, we performed an ex vivo study to find that treatment with the Ara27–siVEGF complex inhibits aorta ring sprouting. Furthermore, the complex did not induce immunotoxicity in THP-1 and RAW264.7 cells. Taken together, our studies demonstrate that an Ara27–siVEGF conjugate is efficient for knockdown of VEGF in HUVECs to inhibit angiogenesis, without marked cytotoxic and immunotoxic effects.
- 7 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0120
Open AccessA Novel Cell-Penetrating Peptide–Vascular Endothelial Growth Factor Small Interfering Ribonucleic Acid Complex That Mediates the Inhibition of Angiogenesis by Human Umbilical Vein Endothelial Cells and in an Ex Vivo Mouse Aorta Ring Model
Angiogenesis is mediated by vascular endothelial growth factor (VEGF), a protein that plays a key role in wound healing, inflammatory diseases, cardiovascular processes, ocular diseases, and tumor growth. Indeed, modulation of angiogenesis represents a potential approach to treating cancer and, as such, therapeutic approaches targeting VEGF and its receptors have been widely investigated as part of the broader search for curative interventions. Equally, RNA interference is a powerful tool for treating diseases, but its application as a disease treatment has been limited in part because of a lack of efficient small interfering RNA (siRNA) delivery systems. The purpose of this study was to characterize an amphipathic cell-penetrating peptide, Ara27, and its potential as an effective delivery vehicle as a conjugate with VEGF siRNA (siVEGF). In our study, we demonstrate that exposure of human umbilical vein endothelial cells (HUVECs) with Ara27–siVEGF complexes did not lead to cytotoxicity and can lead to down-regulation of cellular levels of both VEGF mRNA and protein. Moreover, treatment with the Ara27–siVEGF complex attenuates the phosphorylation of VEGFR2, Akt, and ERK in HUVECs and inhibits their capacity for wound healing and tube formation, both of which characteristics reflective of angiogenesis. In addition, we performed an ex vivo study to find that treatment with the Ara27–siVEGF complex inhibits aorta ring sprouting. Furthermore, the complex did not induce immunotoxicity in THP-1 and RAW264.7 cells. Taken together, our studies demonstrate that an Ara27–siVEGF conjugate is efficient for knockdown of VEGF in HUVECs to inhibit angiogenesis, without marked cytotoxic and immunotoxic effects.
- Open Access
- 1 September 2024
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (4) , 98-106
Y-27632 enables long-term expansion of mouse submandibular gland epithelial cells via inactivation of TGF-β1/CTGF/p38 and ROCK2/JNK signaling pathway
- 1 September 2024
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (4) , 98-106
Open AccessY-27632 enables long-term expansion of mouse submandibular gland epithelial cells via inactivation of TGF-β1/CTGF/p38 and ROCK2/JNK signaling pathway
- Open Access
- 30 March 2024
- Published by The Korean Academy of Preventive Dentistry and Oral Health in Journal of Korean Academy of Oral Health
- Vol. 48 (1) , 9-14
Research on financial estimates to ensure dental care for North Korean residents after unification
Dong-Hun Han, Seung-Pyo Lee, Hoon Myoung, Sang-Ho Roh, Yu-Yi Park, Hye-Ju Lee. J Korean Acad Oral Health 2024;48:9-14. https://doi.org/10.11149/jkaoh.2024.48.1.9
- 30 March 2024
- Published by The Korean Academy of Preventive Dentistry and Oral Health in Journal of Korean Academy of Oral Health
- Vol. 48 (1) , 9-14
Open AccessResearch on financial estimates to ensure dental care for North Korean residents after unification
Dong-Hun Han, Seung-Pyo Lee, Hoon Myoung, Sang-Ho Roh, Yu-Yi Park, Hye-Ju Lee. J Korean Acad Oral Health 2024;48:9-14. https://doi.org/10.11149/jkaoh.2024.48.1.9
- Open Access
- 1 January 2024
- Published by Japanese Association for Laboratory Animal Science in Experimental Animals
- Vol. 73 (2) , 193-202
A survey of the impact of COVID-19 on the management of animal experiments and laboratory animal facilities in Korea
The pandemic has affected the lives of people all over the world. The effects of the pandemic on laboratory animal facilities and their operations through this unusual global event are poorly understood. Here, we have applied a methodological framework of qualitative approach including semi-structured interviews to investigate laboratory animal operations in Korea and how it has shaped the on-going management and laboratory operations of such facilities. A total of fifty-two individuals, including members and administrators of the Institutional Animal Care and Use Committee (IACUC), researchers, and animal facility managers and staff, were surveyed through purposeful sampling. Survey questions explored how the pandemic impacted the IACUC and the functioning of animal facilities, and what steps to take in preparation of a future pandemic-like crisis. Our survey found evidence of an increase in animal experiments in Korea during the pandemic that correlated with increases in research funding during that period, such as for vaccine development. Also, operational challenges due to pandemic-related health issues in personnel were resolved through overtime, rather than by reducing facility operations. Moreover, a refinement of post-approval monitoring (PAM) practices was also discussed by respondents. Taken together, our study offers insights into animal facility operations during the pandemic and outlines recommendations for safeguarding operations in such future scenarios.
- 1 January 2024
- Published by Japanese Association for Laboratory Animal Science in Experimental Animals
- Vol. 73 (2) , 193-202
Open AccessA survey of the impact of COVID-19 on the management of animal experiments and laboratory animal facilities in Korea
The pandemic has affected the lives of people all over the world. The effects of the pandemic on laboratory animal facilities and their operations through this unusual global event are poorly understood. Here, we have applied a methodological framework of qualitative approach including semi-structured interviews to investigate laboratory animal operations in Korea and how it has shaped the on-going management and laboratory operations of such facilities. A total of fifty-two individuals, including members and administrators of the Institutional Animal Care and Use Committee (IACUC), researchers, and animal facility managers and staff, were surveyed through purposeful sampling. Survey questions explored how the pandemic impacted the IACUC and the functioning of animal facilities, and what steps to take in preparation of a future pandemic-like crisis. Our survey found evidence of an increase in animal experiments in Korea during the pandemic that correlated with increases in research funding during that period, such as for vaccine development. Also, operational challenges due to pandemic-related health issues in personnel were resolved through overtime, rather than by reducing facility operations. Moreover, a refinement of post-approval monitoring (PAM) practices was also discussed by respondents. Taken together, our study offers insights into animal facility operations during the pandemic and outlines recommendations for safeguarding operations in such future scenarios.